Israeli Drugmaker Can Intervene In $163M Perrigo-US Row

Law360 (February 14, 2020, 6:25 PM EST) -- A Michigan federal judge on Friday partially granted an Israeli drugmaker permission to intervene in Perrigo's suit to recoup a $163.5 million tax refund, but only to the extent necessary to safeguard its trade secrets.

Dexcel Pharma Technologies Ltd., which made an agreement with generic drugmaker Perrigo Company PLC for distribution of a heartburn medication, has shown enough legal interest to intervene in the case to protect its proprietary information, U.S. Magistrate Judge Phillip J. Green said in his order.

However, Judge Green found that Dexcel failed to give sufficient reason for its proposals to proceed in a closed courtroom while...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!